Skip to content

Abre™ AB9U16060090Recalls & reported problems

Medtronic, Inc. · STENT AB9U16060090 ABRE V01 · Class 3 · Implant

All models of Abre (26)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
5
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00643169796331), received between Feb 23, 2021 and Aug 6, 2026 — classified as 1 injury, 4 malfunctions.

The most frequently reported specific device problem is “Fracture” (2 reports).

3 other recalls cover devices cleared under the same FDA submission (P200026); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 1 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Fracture2
  • Premature Activation2
  • Activation, Positioning or Separation Problem1
  • Material Deformation1

Patient problems

  • No Clinical Signs, Symptoms or Conditions4
  • Unspecified Tissue Injury1

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • MalfunctionAug 6, 2026Fracture; Activation, Positioning or Separation Problem

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50153817 ↗
  • MalfunctionJun 22, 2022Fracture; Fracture

    LIMITED INFORMATION REPORTED THAT PHYSICIAN IMPLANTED 3 NON-MEDTRONIC VENOUS STENT (VICI): ONE IN THE IN THE LEFT ILIAC 16X120X100 AND 2 IN THE EXTERNAL RIGHT ILIAC, 16X90X100 IN 2020. ONE YEAR LATER THE LEFT STENT WAS OCCLUDED, VENOGRAM, LYSIS CATHETER, THROMBECTOMY. ABRE SELF-EXPANDING BARE METAL STENT LEFT STENT FRACTURE ¿ VENOGRAM LEFT. NO FURTHER INFORMATION AVAILABLE

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14769480 ↗
  • MalfunctionApr 29, 2022Premature Activation; Premature Activation

    PHYSICIAN USED AN ABRE SELF-EXPANDING STENT DURING TREATMENT OF A LESION IN THE PATIENT'S LEFT COMMON ILIAC VEIN. THERE WAS NO DAMAGE NOTED TO PACKAGING (I.E. SHELF CARTON, HOOP/TRAY). NO ISSUES WERE NOTED WHEN REMOVING THE DEVICE FROM THE HOOP/TRAY. THE DEVICE WAS PREPPED AS PER IFU WITHOUT ISSUE. THE DEVICE WAS NOT PASSED THROUGH A PREVIOUSLY DEPLOYED STENT AND NO RESISTANCE WAS ENCOUNTERED DURING ADVANCEMENT.. DEPLOYMENT ISSUES ARE REPORTED. THE THUMBSCREW/LOCK-PIN WAS CHECKED FOR SECUREMENT PRIOR TO PROCEDURE AND REMOVED PRIOR TO DEPLOYMENT OF THE STENT. THE STENT WAS ATTEMPTED TO REPOSITION PULLING STENT BACK SLIGHTLY AND IT DEPLOYED ON ITS OWN. THERE WAS NO ATTEMPTS MADE TO REMOVE THE STENT. THERE WAS NO DEFORMATION NOTED TO THE DEPLOYED STENT. THE DELIVERY SYSTEM WAS SAFELY REMOVED. THERE WAS NO VESSEL DAMAGE NOTED. A SECOND STENT WAS PLACED TO EXTEND FROM THE FIRST ONE. NO PATIENT INJURY REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 14247871 ↗
  • MalfunctionApr 28, 2021Premature Activation; Premature Activation

    IT WAS REPORTED THAT A PHYSICIAN WAS ATTEMPTING TO USE A ABRE SELF-EXPANDING STENT DEVICE TO TREAT A LESION IN THE LEFT DISTAL COMMON ILIAC VEIN IN A PATIENT. IFU WAS FOLLOWED WITH NO ISSUES NOTED. IT WAS REPORTED THAT DEPLOYMENT DIFFICULTIES OCCURRED ¿ THE PHYSICIAN DEPLOYED STENT PARTIALLY WITH INTENT TO REPOSITION. UPON ATTEMPTING TO REPOSITION, STENT LOCKED INTO PLACE IN VESSEL AND AS PHYSICIAN PULLED BACK, STENT WAS DEPLOYED IN VESSEL WITHOUT USING THUMBWHEEL TO RELEASE STENT. THUMBSCREW/LOCK-PIN WAS CHECKED FOR SECUREMENT PRIOR TO PROCEDURE. THE LOCK-PIN REMOVED PRIOR TO STENT DELIVERY. THE LESION WAS NOT PREDILATED, DID NOT PASS THROUGH A PREVIOUSLY DEPLOYED STENT. NO RESISTANCE WAS ENCOUNTERED, AND NO EXCESSIVE FORCE WAS USED. THE PROCEDURE WAS COMPLETED BY PULLING BACK THE DELIVERY CATHETER AND THE STENT CAME OUT OF DEVICE INTO VESSEL WITHOUT USING THUMBWHEEL FOR DELIVERY. NO PATIENT INJURY REPORTED FOR THIS EVENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 11738177 ↗
  • InjuryFeb 23, 2021Material Deformation; Material Deformation

    PHYSICIAN WAS ATTEMPTING TO USE THE ABRE VENOUS SELF-EXPANDING STENT DURING PROCEDURE TO TREAT A NONE CALCIFIED PLAQUE LESION IN THE LEFT PROXIMAL COMMON ILIAC VEIN (CIV) . THE VESSEL DIAMETER AND LESION LENGTH ARE 14MMAND 50MM RESPECTIVELY. NO EMBOLIC PROTECTION WAS USED. THERE WAS NO DAMAGE NOTED TO PACKAGING. THERE WAS NO ISSUE NOTED WHEN REMOVING THE DEVICE FROM HOOP/TRAY. THE DEVICE WAS PREPPED PER IFU WITH NO ISSUES IDENTIFIED. IMPROPER DEPLOYMENT ISSUE OCCURRED. THE THUMBSCREW/LOCK-PIN WAS CHECKED FOR SECUREMENT PRIOR TO PROCEDURE. THE LOCK-PIN WAS REMOVED PRIOR TO DEPLOYMENT WITH STENT ACROSS THE LESION. THE VESSEL WAS NOT PRE DILATED. THE DEVICE DID NOT PASS THROUGH A PREVIOUSLY DEPLOYED STENT. THERE WAS RESISTANCE ENCOUNTERED WHEN ADVANCING THE DEVICE WITH NO EXCESSIVE FORCE USED. IT WAS REPORTED THAT THE STENT WAS FULLY DEPLOYED AFTER INFLATION WITH A 10X40 NON-MEDTRONIC BALLOON. THE STENT WAS SLI GHTLY BELOW TARGET BUT FULLY APPOSED TO VESSEL WALL VIA IVUS. PATIENT HAD VARIOUS LEVELS OF DISEASE FROM SUPERFICIAL THROUGH AND INTO THE CIV. POPLITEAL ACCESS. NO PRE DIL OF ANY ZONE BEFORE STENTING THE COMMON ILIAC. THERE WERE ISSUES ADVANCING THE STENT THROUGH THE SUPERFICIA

    Patient problems: Unspecified Tissue Injury

    MAUDE report 11366349 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P200026. One submission often covers many models, so check the product and lot details in each record.

  • Z-1098-2026 · Dec 4, 2025 · Open, Classified
    Abre Venous Self-Expanding Stent System, Model numbers AB9G14120090 AB9G12100090 AB9G14080090 AB9G12080090 AB9U12060090 AB9U14100090 AB9U14080090 AB9U12080090 AB9U14060090 AB9G1410
  • Z-0464-2022 · Nov 19, 2021 · Terminated
    Instructions for Use for all model numbers of the Medtronic Abre Venous Self-Expanding Stent System.
  • Z-1532-2021 · Mar 16, 2021 · Terminated
    Medtronic Abre Venous Self-expanding Sent System, Catalog number REF AB9U16080090 - Product Usage: intended for use in the iliofemoral veins for the treatment of symptomatic venous

Other Stent, iliac vein devices

All Stent, iliac vein devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page